> For the complete documentation index, see [llms.txt](https://docs.rplpeptides.com/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://docs.rplpeptides.com/docs/nadplus/ch01-introduction/nadplus-introduction.md).

# nadplus-introduction

### Chapter 1: Introduction and Overview

### 1.1 Document Purpose

This technical manual provides comprehensive documentation for NAD+ (Nicotinamide Adenine Dinucleotide, Oxidized Form), a fundamental pyridine nucleotide coenzyme. It is intended for research laboratories, procurement professionals, quality assurance teams, biotechnology organizations, and scientific researchers requiring detailed technical information for laboratory research use.

### 1.2 Product Identity

| Field                 | Value                                                   |
| --------------------- | ------------------------------------------------------- |
| **Product Name**      | NAD+ (Nicotinamide Adenine Dinucleotide, Oxidized Form) |
| **Type**              | Biochemical Coenzyme / Pyridine Nucleotide              |
| **CAS Number**        | 53-84-9                                                 |
| **Molecular Formula** | C₂₁H₂₇N₇O₁₄P₂                                           |
| **Molecular Weight**  | 663.43 Da                                               |
| **Purity**            | ≥98% (HPLC)                                             |
| **Appearance**        | White to off-white lyophilized powder                   |
| **Packaging**         | 500 mg, 1000 mg per vial                                |

### 1.3 Classification

NAD+ is classified as a **Biochemical Coenzyme**, specifically a **Pyridine Nucleotide**. It is not a peptide, protein, or any amino acid polymer. As a small-molecule coenzyme, it functions as a critical electron carrier in redox metabolism and serves as a substrate for multiple enzyme families including sirtuins, PARPs (poly-ADP-ribose polymerases), and CD38.

### 1.4 Biological Significance

NAD+ is one of the most abundant and versatile coenzymes in living systems. It participates in over 500 enzymatic reactions and serves two primary functional categories:

1. **Redox Metabolism**: NAD+ shuttles electrons in catabolic and anabolic reactions, cycling between its oxidized (NAD+) and reduced (NADH) forms.
2. **Signaling Substrate**: NAD+ is consumed as a substrate by sirtuins (class III histone deacetylases), PARPs, CD38, and other NAD+-consuming enzymes, producing second messengers such as nicotinamide and ADP-ribose.

### 1.5 Historical Context

| Year          | Milestone                                                                                                         |
| ------------- | ----------------------------------------------------------------------------------------------------------------- |
| 1904          | Arthur Harden and William John Young discover a heat-stable factor ("coferment") essential for yeast fermentation |
| 1906          | Harden and Young identify the factor as a nucleotide-containing coenzyme                                          |
| 1936          | Otto Warburg identifies the coenzyme's role in hydrogen transfer, publishing its structure                        |
| 1937          | Hans von Euler-Chelpin wins the Nobel Prize in Chemistry for work on NAD+ structure and function                  |
| 1963          | Full chemical synthesis of NAD+ is achieved                                                                       |
| 2000s         | NAD+ emerges as a key signaling molecule; sirtuin and PARP pathways elucidated                                    |
| 2010s–present | NAD+ metabolism becomes a major focus in aging research, neurodegeneration, and metabolic disease                 |

### 1.6 Manufacturer Information

| Field              | Value                               |
| ------------------ | ----------------------------------- |
| **Manufacturer**   | Qingdao RPL Biotechnology Co., Ltd. |
| **Brand**          | RPL Peptide                         |
| **Intended Use**   | Laboratory research use only        |
| **Certifications** | COA, HPLC, LC-MS                    |

### 1.7 Document Structure

This technical manual is organized into 18 chapters covering all aspects of NAD+: chemical and physical properties, biochemical classification, synthesis methods, quality control, analytical methods (HPLC, LC-MS, and others), stability studies, solubility and reconstitution, handling and storage protocols, safety information, regulatory compliance, research applications, mechanism of action, references, glossary, and appendices.

Proper documentation and adherence to the protocols described herein are essential for reproducible and reliable laboratory research outcomes.

***

*End of Chapter 1*


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:

```
GET https://docs.rplpeptides.com/docs/nadplus/ch01-introduction/nadplus-introduction.md?ask=<question>&goal=<endgoal>
```

`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.

The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.